Literature DB >> 34761257

SCoV2-MD: a database for the dynamics of the SARS-CoV-2 proteome and variant impact predictions.

Mariona Torrens-Fontanals1, Alejandro Peralta-García1, Carmine Talarico2, Ramon Guixà-González3,4, Toni Giorgino5,6, Jana Selent1.   

Abstract

SCoV2-MD (www.scov2-md.org) is a new online resource that systematically organizes atomistic simulations of the SARS-CoV-2 proteome. The database includes simulations produced by leading groups using molecular dynamics (MD) methods to investigate the structure-dynamics-function relationships of viral proteins. SCoV2-MD cross-references the molecular data with the pandemic evolution by tracking all available variants sequenced during the pandemic and deposited in the GISAID resource. SCoV2-MD enables the interactive analysis of the deposited trajectories through a web interface, which enables users to search by viral protein, isolate, phylogenetic attributes, or specific point mutation. Each mutation can then be analyzed interactively combining static (e.g. a variety of amino acid substitution penalties) and dynamic (time-dependent data derived from the dynamics of the local geometry) scores. Dynamic scores can be computed on the basis of nine non-covalent interaction types, including steric properties, solvent accessibility, hydrogen bonding, and other types of chemical interactions. Where available, experimental data such as antibody escape and change in binding affinities from deep mutational scanning experiments are also made available. All metrics can be combined to build predefined or custom scores to interrogate the impact of evolving variants on protein structure and function.
© The Author(s) 2021. Published by Oxford University Press on behalf of Nucleic Acids Research.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 34761257      PMCID: PMC8689960          DOI: 10.1093/nar/gkab977

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   19.160


  31 in total

1.  The Protein Data Bank.

Authors:  H M Berman; J Westbrook; Z Feng; G Gilliland; T N Bhat; H Weissig; I N Shindyalov; P E Bourne
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  MDTraj: A Modern Open Library for the Analysis of Molecular Dynamics Trajectories.

Authors:  Robert T McGibbon; Kyle A Beauchamp; Matthew P Harrigan; Christoph Klein; Jason M Swails; Carlos X Hernández; Christian R Schwantes; Lee-Ping Wang; Thomas J Lane; Vijay S Pande
Journal:  Biophys J       Date:  2015-10-20       Impact factor: 4.033

3.  CHARMM-GUI: a web-based graphical user interface for CHARMM.

Authors:  Sunhwan Jo; Taehoon Kim; Vidyashankara G Iyer; Wonpil Im
Journal:  J Comput Chem       Date:  2008-08       Impact factor: 3.376

4.  Holo-like and Druggable Protein Conformations from Enhanced Sampling of Binding Pocket Volume and Shape.

Authors:  Andrea Basciu; Giuliano Malloci; Fabio Pietrucci; Alexandre M J J Bonvin; Attilio V Vargiu
Journal:  J Chem Inf Model       Date:  2019-03-28       Impact factor: 4.956

5.  A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology.

Authors:  Andrew Rambaut; Edward C Holmes; Áine O'Toole; Verity Hill; John T McCrone; Christopher Ruis; Louis du Plessis; Oliver G Pybus
Journal:  Nat Microbiol       Date:  2020-07-15       Impact factor: 17.745

6.  Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding.

Authors:  Tyler N Starr; Allison J Greaney; Sarah K Hilton; Daniel Ellis; Katharine H D Crawford; Adam S Dingens; Mary Jane Navarro; John E Bowen; M Alejandra Tortorici; Alexandra C Walls; Neil P King; David Veesler; Jesse D Bloom
Journal:  Cell       Date:  2020-08-11       Impact factor: 41.582

7.  Establishment and lineage dynamics of the SARS-CoV-2 epidemic in the UK.

Authors:  Louis du Plessis; John T McCrone; Alexander E Zarebski; Verity Hill; Christopher Ruis; Moritz U G Kraemer; Andrew Rambaut; Oliver G Pybus; Bernardo Gutierrez; Jayna Raghwani; Jordan Ashworth; Rachel Colquhoun; Thomas R Connor; Nuno R Faria; Ben Jackson; Nicholas J Loman; Áine O'Toole; Samuel M Nicholls; Kris V Parag; Emily Scher; Tetyana I Vasylyeva; Erik M Volz; Alexander Watts; Isaac I Bogoch; Kamran Khan; David M Aanensen
Journal:  Science       Date:  2021-01-08       Impact factor: 47.728

8.  Crystal Structure of SARS-CoV-2 Main Protease in Complex with the Non-Covalent Inhibitor ML188.

Authors:  Gordon J Lockbaum; Archie C Reyes; Jeong Min Lee; Ronak Tilvawala; Ellen A Nalivaika; Akbar Ali; Nese Kurt Yilmaz; Paul R Thompson; Celia A Schiffer
Journal:  Viruses       Date:  2021-01-25       Impact factor: 5.048

9.  UniProt: the universal protein knowledgebase in 2021.

Authors: 
Journal:  Nucleic Acids Res       Date:  2021-01-08       Impact factor: 16.971

10.  SARS-CoV-2 simulations go exascale to predict dramatic spike opening and cryptic pockets across the proteome.

Authors:  Maxwell I Zimmerman; Justin R Porter; Michael D Ward; Sukrit Singh; Neha Vithani; Artur Meller; Upasana L Mallimadugula; Catherine E Kuhn; Jonathan H Borowsky; Rafal P Wiewiora; Matthew F D Hurley; Aoife M Harbison; Carl A Fogarty; Joseph E Coffland; Elisa Fadda; Vincent A Voelz; John D Chodera; Gregory R Bowman
Journal:  Nat Chem       Date:  2021-05-24       Impact factor: 24.427

View more
  4 in total

1.  Biochemical Characterization of Emerging SARS-CoV-2 Nsp15 Endoribonuclease Variants.

Authors:  Isha M Wilson; Meredith N Frazier; Jian-Liang Li; Thomas A Randall; Robin E Stanley
Journal:  bioRxiv       Date:  2022-05-12

2.  The 2022 Nucleic Acids Research database issue and the online molecular biology database collection.

Authors:  Daniel J Rigden; Xosé M Fernández
Journal:  Nucleic Acids Res       Date:  2022-01-07       Impact factor: 16.971

Review 3.  Potential Resistance of SARS-CoV-2 Main Protease (Mpro) against Protease Inhibitors: Lessons Learned from HIV-1 Protease.

Authors:  János András Mótyán; Mohamed Mahdi; Gyula Hoffka; József Tőzsér
Journal:  Int J Mol Sci       Date:  2022-03-23       Impact factor: 5.923

4.  Entrectinib-A SARS-CoV-2 Inhibitor in Human Lung Tissue (HLT) Cells.

Authors:  Alejandro Peralta-Garcia; Mariona Torrens-Fontanals; Tomasz Maciej Stepniewski; Judith Grau-Expósito; David Perea; Vikram Ayinampudi; Maria Waldhoer; Mirjam Zimmermann; María J Buzón; Meritxell Genescà; Jana Selent
Journal:  Int J Mol Sci       Date:  2021-12-18       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.